|
Market Closed -
Nasdaq
16:00:00 2026-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 123.98 USD | -1.42% |
|
-3.38% | -28.76% |
| 08-24 | Insmed Incorporated Receives Approval for BRINSUPRI for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japan | CI |
| 08-24 | Insmed's Lung Disease Drug Gets Approved in Japan | MT |
| Market Cap | 27.07B 23.2B 21.71B 19.85B 37.45B 2,592B 37.85B 257B 99.88B 1,302B 102B 99.46B 4,307B | P/E 2026 * |
-78.4x | P/E 2027 * | 114x |
|---|---|---|---|---|---|
| Enterprise Value | 26.44B 22.66B 21.2B 19.38B 36.58B 2,532B 36.96B 251B 97.55B 1,271B 99.29B 97.14B 4,207B | EV / Sales 2026 * |
14.6x | EV / Sales 2027 * | 8.98x |
| Free-Float |
99.49% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Insmed Incorporated
| 1 day | -1.42% | ||
| 1 week | -3.38% | ||
| Current month | +25.74% | ||
| 1 month | +15.96% | ||
| 3 months | +16.70% | ||
| 6 months | -21.84% | ||
| Current year | -28.76% |
| 1 week | 122.83 |  | 131.1 |
| 1 month | 96.42 | | 137.7 |
| Current year | 90.39 | | 186.19 |
| 1 year | 90.39 | | 212.75 |
| 3 years | 21.21 | | 212.75 |
| 5 years | 16.04 | | 212.75 |
| 10 years | 10.21 | | 212.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Will Lewis
CEO | Chief Executive Officer | 57 | 2012-09-09 |
Sara Bonstein
DFI | Director of Finance/CFO | 45 | 2020-01-30 |
Martina Flammer
CTO | Chief Tech/Sci/R&D Officer | 62 | 2019-12-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Melvin Sharoky
CHM | Chairman | 75 | 2009-06-15 |
Will Lewis
CHM | Chairman | 57 | 2018-11-07 |
David Brennan
BRD | Director/Board Member | 72 | 2014-05-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/17/26 | Sell | Director | -5,000 | 0.0023% | ||
| 8/10/26 | Fiscal year | Chief Operating Officer | 719,550 | 0.3320% | ||
| 8/6/26 | Fiscal year | Chief Technology Officer | 81,519 | 0.0376% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.42% | -3.38% | -5.99% | +465.34% | 27.07B | |
| -4.31% | -6.62% | +65.79% | +98.02% | 69.06B | |
| -4.19% | +1.05% | +52.79% | +85.53% | 63.06B | |
| -3.22% | +23.17% | +1.75% | -5.23% | 28.34B | |
| +5.04% | +4.78% | +52.94% | +14.77% | 25.45B | |
| -1.81% | +0.38% | +34.52% | -18.33% | 19.69B | |
| +5.36% | +4.61% | +270.18% | +415.10% | 19.19B | |
| -1.05% | -4.33% | +10.47% | +513.84% | 15.95B | |
| +0.87% | +4.26% | +41.21% | +150.80% | 13.52B | |
| -0.44% | -2.22% | +306.61% | +209.31% | 12.25B | |
| Average | -0.52% | +2.72% | +83.03% | +192.91% | 29.36B | |
| Weighted average by Cap. | -1.74% | +1.50% | +66.26% | +154.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.81B 1.55B 1.45B 1.32B 2.5B 173B 2.53B 17.14B 6.66B 86.85B 6.78B 6.64B 287B | 2.89B 2.47B 2.31B 2.12B 3.99B 276B 4.03B 27.38B 10.65B 139B 10.84B 10.6B 459B |
| Net income | -349M -299M -280M -256M -483M -33.45B -488M -3.31B -1.29B -16.8B -1.31B -1.28B -55.58B | 211M 181M 170M 155M 292M 20.25B 296M 2.01B 780M 10.17B 794M 777M 33.64B |
| Net Debt | -632M -541M -507M -463M -874M -60.5B -883M -5.99B -2.33B -30.38B -2.37B -2.32B -101B | -1.16B -991M -927M -848M -1.6B -111B -1.62B -10.97B -4.27B -55.61B -4.34B -4.25B -184B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-24 | US$123.98 | -1.42% | 1,341,042 |
| 26-08-21 | US$125.77 | +0.55% | 1,124,491 |
| 26-08-20 | US$125.08 | -4.27% | 1,761,850 |
| 26-08-19 | US$130.66 | +1.71% | 1,493,674 |
| 26-08-18 | US$128.46 | +0.11% | 1,274,119 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INSM Stock
Select your edition
All financial news and data tailored to specific country editions
